View of EVALUATION OF THE EFFECTIVENESS OF TREATMENT OF HEART FAILURE WITH REDUCED LEFT VENTORIAL EJECTION FRACTION WITH DAPAGLIFLOZIN DRUG COMBINATION AT BAC LIEU GENERAL HOSPITAL IN 2023-2024

Return to Article Details EVALUATION OF THE EFFECTIVENESS OF TREATMENT OF HEART FAILURE WITH REDUCED LEFT VENTORIAL EJECTION FRACTION WITH DAPAGLIFLOZIN DRUG COMBINATION AT BAC LIEU GENERAL HOSPITAL IN 2023-2024 Download Download PDF